The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 4, 2011, Pages 372-379

  Rwigema, Jean Claude M ^a   Heron, Dwight E ^a   Ferris, Robert L ^a   Andrade, Regiane S ^a   Gibson, Michael K ^a   Yang, Yong ^a   Ozhasoglu, Cihat ^a   Argiris, Athanassios E ^a   Grandis, Jennifer R ^a   Burton, Steven A ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

head and neck cancer; outcome; radiation dose; reirradiation; stereotactic body radiotherapy; tumor volume

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYBERKNIFE; EVALUATION AND FOLLOW UP; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOSURGERY; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 79961172037     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181e84dc0     Document Type: Article

References (42)

1. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locoregionally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952. (Pubitemid 38580197)
2. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
3. Bourhis J, Le Maitre A, Baujat B, et al. Individual patients' data metaanalyses in head and neck cancer. Curr Opin Oncol. 2007;19:188-194. (Pubitemid 46597476)
4. Brockstein B, Haraf DJ, Rademaker AW, et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: A 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004;15:1179-1186. (Pubitemid 39199304)
5. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-2098. (Pubitemid 37464533)
6. Hall SF, Groome PA, Irish J, et al. The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope. 2008;118: 1362-1371.
7. Siddiqui F, Patel M, Khan M, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys. 2009;74:1047-1053.
8. Roh KW, Jang JS, Kim MS, et al. Fractionated stereotactic radiotherapy as re-irradiation for locoregionally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2009;74:1348-1355.
9. Unger KR, Lominska CE, Deeken JF, et al. Fractionated stereotactic radiosurgery for re-irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010 Jul 23. [Epub ahead of print].
10. Voynov G, Heron DE, Burton S, et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat. 2006;5:529-535. (Pubitemid 44606275)
11. Heron DE, Ferris RL, Karamouzis M, et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: Results of a phase i dose-escalation trial. Int J Radiat Oncol Biol Phys. 2009;75:1493-1500.
12. Rwigema JC, Heron DE, Ferris RL, et al. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma-updated report of the university of Pittsburgh experience. Am J Clin Oncol. 2010 Jun; 33(3):286-293.
13. Chappell R, Nondahl DM, Fowler JF. Modeling dose and locoregional control in radiotherapy. J Am Stat Assoc. 1995;90:829-838.
14. Fuller LM, Krasin MJ, Velasquez WS, et al. Significance of tumor size and radiation dose to locoregional control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys. 1995;31:3-11.
15. Loo BW, Shen J, Quinlan-Davidson S, et al. Tumor size is a critical determinant of locoregional control in single fraction stereotactic radiotherapy of pulmonary tumors. Int J Radiat Oncol Biol Phys. 2008;72(suppl): S467-S468.
16. Gerszten PC, Ozhasoglu C, Burton S, et al. Cyberknife frameless stereotactic radiosurgery for spinal lesions: Clinical experience in 125 cases. Neurosurgery. 2004;55:89-98. (Pubitemid 38859082)
17. Guthrie BL, Adler JR Jr. Computer-assisted preoperative planning, interactive surgery, and frameless stereotaxy. Clin Neurosurg. 1992;38:112-131.
18. Murphy MJ, Cox RS. The accuracy of dose locoregionalization for an image-guided frameless radiosurgery system. Med Phys. 1996;23:2043-2049. (Pubitemid 27023702)
19. Adler JR Jr, Chang SD, Murphy MJ, et al. The CyberKnife: A frameless robotic system for radiosurgery. Stereotact Funct Neurosurg. 1997;69:124-128. (Pubitemid 28305430)
20. Chang SD, Main W, Martin DP, et al. An analysis of the accuracy of the Cyberknife: A robotic frameless stereotactic radiosurgical system. Neurosurgery. 2003;52:140-147. (Pubitemid 36098663)
21. Andrade R, Heron DE, Degirmenci B, et al. Post-treatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65: 1315-1322. (Pubitemid 44425218)
22. Meeks SL, Bova FJ, Wagner TH, et al. Image locoregionalization for frameless stereotactic radiotherapy. Int J Radiat Oncol Biol Phys. 2000;46: 1291-1299. (Pubitemid 30139442)
23. Tsuchida Y, Therasse P. Response evaluation criteria in solid tumors (RECIST): New guidelines. Med Pediatr Oncol. 2001;37:1-3. (Pubitemid 32613627)
24. Dawson LA, Myers LL, Bradford CR, et al. Conformal re-irradiation of recurrent and new primary head and neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:377-385. (Pubitemid 32472266)
25. Stevens KR Jr, Britsch A, Moss WT. High-dose re-irradiation of head and neck cancer with curative intent. Int J Radiat Oncol Biol Phys. 1994;29:687-698. (Pubitemid 24241307)
26. Pomp J, Levendag PC, van Putten WL. Reirradiation of recurrent tumors in the head and neck. Am J Clin Oncol. 1988;11:543-549.
27. Kao J, Garofalo MC, Milano MT, et al. Re-irradiation of recurrent and second primary head and neck malignancies: A comprehensive review. Cancer Treat Rev. 2003;29:21-30. (Pubitemid 36395520)
28. Goodwin WJ Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? Laryngoscope. 2000;110:1-18.
29. Regine WF, Valentino J, Patel P, et al. Efficacy of postoperative radiation therapy for recurrent squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1997;39:297-302.
30. Wong LY, Wei WI, Lam LK, et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003; 25:953-959. (Pubitemid 37323011)
31. Kim AJ, Suh JD, Sercarz JA, et al. Salvage surgery with free flap reconstruction: Factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope. 2007;117:1019-1023. (Pubitemid 46869838)
32. Specenier PM, Vermorken JB. Recurrent head and neck cancer: Current treatment and future prospects. Expert Rev Anticancer Ther. 2008;8:375-391. (Pubitemid 351836286)
33. Doweck I, Denys D, Robbins KT. Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope. 2002;112:1742-1749.
34. Haraf DJ, Weichselbaum RR, Vokes EE. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol. 1996;7:913-918. (Pubitemid 26426265)
35. Langlois D, Exchwege F, Kramar A, et al. Reirradiation of head and neck cancers. Presentation of 35 cases treated at the Gustave Roussy Institute. Radiother Oncol. 1985;3:27-33.
36. Salama JK, Vokes EE, Chmura SJ, et al. Long-term outcome of concurrent chemotherapy and re-irradiation for recurrent and second primary head-andneck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:382-391. (Pubitemid 43083422)
37. De Crevoisier R, Bourhis J, Domenge C, et al. Full-dose re-irradiation for unresectable head and neck carcinoma: Experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol. 1998;16:3556-3562. (Pubitemid 28506768)
38. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: Re-irradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2001;51:1299-1304. (Pubitemid 33116324)
39. Pai P, Chuang C, Wei K, et al. Stereotactic radiosurgery for locoregionally recurrent nasopharyngeal carcinoma. Head Neck. 2002;24:748-753. (Pubitemid 34857300)
40. Chua D, Sham J, Hung KN, et al. salvage treatment for persistent and recurrent T1-2 nasopharyngeal carcinoma by stereotactic radiosurgery. Head Neck. 2001;23:791-798. (Pubitemid 32754870)
41. Ryu S, Khan M, Yin F, et al. Image-guided radiosurgery of head and neck cancers. Otolaryngol Head Neck Surg. 2004;130:690-697. (Pubitemid 38881221)
42. Heron DE, Rwigema JC, Gibson MK, et al. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: A single institution matched case-control study. Am J Clin Oncol. 2010 Aug 3. [Epub ahead of print].